Literature DB >> 22391559

Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress.

X Zhou1, Q Hao, J Liao, Q Zhang, H Lu.   

Abstract

The MDM2-p53 feedback loop is crucially important for restricting p53 level and activity during normal cell growth and proliferation, and is thus subjected to dynamic regulation in order for cells to activate p53 upon various stress signals. Several ribosomal proteins, such as RPL11, RPL5, RPL23, RPL26 or RPS7, have been shown to have a role in regulation of this feedback loop in response to ribosomal stress. Here, we identify another ribosomal protein S14, which is highly associated with 5q-syndrome, as a novel activator of p53 by inhibiting MDM2 activity. We found that RPS14, but not RPS19, binds to the central acidic domain of MDM2, similar to RPL5 and RPL23, and inhibits its E3 ubiquitin ligase activity toward p53. This RPS14-MDM2 binding was induced upon ribosomal stress caused by actinomycin D or mycophenolic acid. Overexpression of RPS14, but not RPS19, elevated p53 level and activity, leading to G1 or G2 arrest. Conversely, knockdown of RPS14 alleviated p53 induction by these two reagents. Interestingly, knockdown of either RPS14 or RPS19 caused a ribosomal stress that led to p53 activation, which was impaired by further knocking down the level of RPL11 or RPL5. Together, our results demonstrate that RPS14 and RPS19 have distinct roles in regulating the MDM2-p53 feedback loop in response to ribosomal stress.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22391559      PMCID: PMC3736832          DOI: 10.1038/onc.2012.63

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  60 in total

1.  MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2.

Authors:  Yetao Jin; Shelya X Zeng; Xiao-Xin Sun; Hunjoo Lee; Christine Blattner; Zhixiong Xiao; Hua Lu
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

2.  Acetylation is indispensable for p53 activation.

Authors:  Yi Tang; Wenhui Zhao; Yue Chen; Yingming Zhao; Wei Gu
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

3.  Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.

Authors:  Mu-Shui Dai; Xiao-Xin Sun; Hua Lu
Journal:  Mol Cell Biol       Date:  2008-04-21       Impact factor: 4.272

4.  Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11.

Authors:  Masato Sasaki; Kohichi Kawahara; Miki Nishio; Koshi Mimori; Ryunosuke Kogo; Koichi Hamada; Bunsho Itoh; Jia Wang; Yukako Komatsu; Yong Ryoul Yang; Hiroki Hikasa; Yasuo Horie; Takayuki Yamashita; Takehiko Kamijo; Yanping Zhang; Yan Zhu; Carol Prives; Toru Nakano; Tak Wah Mak; Takehiko Sasaki; Tomohiko Maehama; Masaki Mori; Akira Suzuki
Journal:  Nat Med       Date:  2011-07-31       Impact factor: 53.440

5.  Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.

Authors:  Yaara Ofir-Rosenfeld; Kristy Boggs; Dan Michael; Michael B Kastan; Moshe Oren
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

6.  Inhibition of c-Myc activity by ribosomal protein L11.

Authors:  Mu-Shui Dai; Hugh Arnold; Xiao-Xin Sun; Rosalie Sears; Hua Lu
Journal:  EMBO J       Date:  2007-06-28       Impact factor: 11.598

7.  Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11.

Authors:  Xiao-Xin Sun; Mu-Shui Dai; Hua Lu
Journal:  J Biol Chem       Date:  2008-02-27       Impact factor: 5.157

8.  Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients.

Authors:  Hanna T Gazda; Mee Rie Sheen; Adrianna Vlachos; Valerie Choesmel; Marie-Françoise O'Donohue; Hal Schneider; Natasha Darras; Catherine Hasman; Colin A Sieff; Peter E Newburger; Sarah E Ball; Edyta Niewiadomska; Michal Matysiak; Jan M Zaucha; Bertil Glader; Charlotte Niemeyer; Joerg J Meerpohl; Eva Atsidaftos; Jeffrey M Lipton; Pierre-Emmanuel Gleizes; Alan H Beggs
Journal:  Am J Hum Genet       Date:  2008-12       Impact factor: 11.025

9.  Identification of mutations in the ribosomal protein L5 (RPL5) and ribosomal protein L11 (RPL11) genes in Czech patients with Diamond-Blackfan anemia.

Authors:  Radek Cmejla; Jana Cmejlova; Helena Handrkova; Jiri Petrak; Kvetoslava Petrtylova; Vladimir Mihal; Jan Stary; Zdena Cerna; Yahia Jabali; Dagmar Pospisilova
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

10.  Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.

Authors:  Benjamin L Ebert; Jennifer Pretz; Jocelyn Bosco; Cindy Y Chang; Pablo Tamayo; Naomi Galili; Azra Raza; David E Root; Eyal Attar; Steven R Ellis; Todd R Golub
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

View more
  77 in total

1.  Cyclic avian mass mortality in the northeastern United States is associated with a novel orthomyxovirus.

Authors:  Andrew B Allison; Jennifer R Ballard; Robert B Tesh; Justin D Brown; Mark G Ruder; M Kevin Keel; Brandon A Munk; Randall M Mickley; Samantha E J Gibbs; Amelia P A Travassos da Rosa; Julie C Ellis; Hon S Ip; Valerie I Shearn-Bochsler; Matthew B Rogers; Elodie Ghedin; Edward C Holmes; Colin R Parrish; Chris Dwyer
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Scission of the p53-MDM2 Loop by Ribosomal Proteins.

Authors:  Xiang Zhou; Jun-Ming Liao; Wen-Juan Liao; Hua Lu
Journal:  Genes Cancer       Date:  2012-03

Review 3.  Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors:  Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2014-08-28       Impact factor: 12.944

Review 4.  Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1.

Authors:  Xiao-Xin Sun; Mu-Shui Dai
Journal:  World J Biol Chem       Date:  2014-05-26

Review 5.  Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.

Authors:  Yongchao Zhao; Meredith A Morgan; Yi Sun
Journal:  Antioxid Redox Signal       Date:  2014-02-20       Impact factor: 8.401

6.  GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis.

Authors:  Kota Kayama; Shinya Watanabe; Takuya Takafuji; Takahiro Tsuji; Kensuke Hironaka; Masaki Matsumoto; Keiichi I Nakayama; Masato Enari; Takashi Kohno; Kouya Shiraishi; Tohru Kiyono; Kazumasa Yoshida; Nozomi Sugimoto; Masatoshi Fujita
Journal:  EMBO Rep       Date:  2016-11-17       Impact factor: 8.807

Review 7.  GRWD1, a new player among oncogenesis-related ribosomal/nucleolar proteins.

Authors:  Takuya Takafuji; Kota Kayama; Nozomi Sugimoto; Masatoshi Fujita
Journal:  Cell Cycle       Date:  2017-07-19       Impact factor: 4.534

8.  MMP9 inhibition increases erythropoiesis in RPS14-deficient del(5q) MDS models through suppression of TGF-β pathways.

Authors:  Minyoung Youn; Haigen Huang; Cheng Chen; Sharon Kam; Mark C Wilkes; Hee-Don Chae; Kunju J Sridhar; Peter L Greenberg; Bertil Glader; Anupama Narla; Shuo Lin; Kathleen M Sakamoto
Journal:  Blood Adv       Date:  2019-09-24

Review 9.  Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.

Authors:  Tiffany Devine; Mu-Shui Dai
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  The Many Faces of MDM2 Binding Partners.

Authors:  Maurisa F Riley; Guillermina Lozano
Journal:  Genes Cancer       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.